Skip to main content
Premium Trial:

Request an Annual Quote

Gregory McGuinness, George Poste, Jake Orville, Roman Zastawny, Debra Schneider

NimbleGen Systems has named Gregory McGuinness to be its vice president of international business.
McGuinness is former director of European business development for Gene Logic, and was director of channel management for Affymetrix and director of sales and distributor relations for Genetic Microsystems. He also worked with Stratagene, PerkinElmer, and Applied Biosystems.

Caris Diagnostics has named George Poste as an outside director to its board of directors, the company said last week.
Poste is a senior technical advisor at Caris, which has a controlling stake in Caris Diagnostics.
Poste also is director of the Biodesign Institute at Arizona State University, a biotech/nanotech program, and he is chief executive at Health Technology Networks, a genomics consulting company.
Poste is a fellow of the Royal Society and the UK Academy of Medicine, a distinguished fellow at the Hoover Institution of Stanford University and a member of the Council for Foreign Relations.

NextGen has appointed Jake Orville as vice president of global sales.
Orville comes to NextGen from Third Wave Technologies, where he served as vice president of sales and business development.
Orville replaces Geoff Alms, who moves to a lead role in North American development at NextGen.

GeneNews has named Roman Zastawny vice president of biomarker development.
Zastawny was previously vice president of R&D at Tm Bioscience, where he led a team to gain FDA clearance for a cystic fibrosis diagnostic, and vice president of development at Novx Systems, where he worked to get a product cleared by Canadian health officials.

Transgenomic has hired Debra Schneider as vice president and chief financial officer, effective Dec. 4.
Schneider comes to Transgenomic from First Data Corporation, where for 17 years she worked in various capacities, including serving as CFO for business interests and as vice president of finance.

Filed under

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.